Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
04/11/2025 12:38
Nov 4 (Reuters) - Evoke Pharma Inc EVOK.O: EVOKE PHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY QOL MEDICAL EVOKE PHARMA INC: PROPOSED DEAL FOR FOR $11.00 PER SHARE IN CASH AT CLOSING Source text: ID:nGNX1C5Csz Further company coverage: EVOK.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary